Search the Site
join our mailing list
subscriber login
.jpg)
PO Box 9905
Washington
DC 20016
| ISSUE 44 - NOV. 21, 2014 |
As FDA Weighs its Options on Morcellation, Debate Erupts Over Harvard Device Study
Here is what we know: A surgical device used to perform about 100,000 hysterectomies and myomectomies every year in the U.S. has been shown to spread cells from undetected or missed uterine cancers—rapidly upstaging the disease.
And here is what we don’t know: What will FDA do about it?
The agency is under pressure to respond to the growing outcry from patient advocates, who want a ban on the device.
 |
Conversation with The Cancer Letter Demetri: Morcellation Worsens Outcomes In Patients with Undiagnosed Cancers As an oncologist who treats sarcoma, George Demetri has seen the adverse consequences of power morcellation, the surgical technique widely used to perform laparoscopic hysterectomies and remove putative fibroids. In a small minority of cases, these fibroids instead represent unsuspected malignancies—including rare and aggressive leiomyosarcomas—which were impossible to detect prior to the morcellation procedure. |
|
The Cancer Letter is taking a Thanksgiving Break. The next issue will be published on Dec. 5. |
|
 |
The Cancer Prevention and Research Institute of Texas awarded 20 grants through its product development program, five grants through its prevention program, and seven recruitment grants through its research program, totaling more than $65 million. |
 |
ASCO Proposes Principles For Future Debate on Medicaid The American Society of Clinical Oncology has proposed a set of principles for shaping future debate of the role of Medicaid. |
 |
Connie Curran, 67, C-Change Executive Director Connie Curran, 67, the first executive director of C-Change, died Nov. 10. C-Change brings together leaders in cancer from the public, private, and not-for-profit sectors. Curran was born in Berlin, Wis. She held degrees from the University of Wisconsin, DePaul University, and Northern Illinois University. She also is a graduate of Harvard University Business School’s Owner/President Management program. |
 |
|
 |
In Brief
|
